| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GO | Common Stock | Options Exercise | $47,625 | +12,500 | +51% | $3.81* | 37,059 | 10 Sep 2020 | Direct | |
| transaction | GO | Common Stock | Sale | $490,750 | -12,500 | -34% | $39.26 | 24,559 | 10 Sep 2020 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GO | Stock Options (Right to Buy) | Options Exercise | $0 | -12,500 | -4% | $0.000000 | 298,311 | 10 Sep 2020 | Common Stock | 12,500 | $3.81 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a previously adopted Rule 10b5-1 trading plan. |
| F2 | Represents previously granted stock options which were deemed earned and acquired upon the satisfaction of certain performance vesting criteria. These stock options are vested and exercisable. |
This Form 4 is being amended solely to restate the outstanding balances reported in Column 5 of Table 1. Due to an administrative error, such balances were incorrectly reported in the original Form 4 filed September 14, 2020.